Navigation Links
Many American senior citizens fall into the “Doughnut Hole”!

The Starks take prescription drugs worth $200 every month for several problems ranging from arthritis to emphysema and heart failure. So, Donna and Grover Stark enrolled// in Medicare Part D, the new federal prescription-drug plan, last December.

Since the Coventry AdvantraRx plan paid for most of their drugs, minus $20 copays, the Starks were ecstatic. Suddenly, one day the coverage stopped. Donna was told by a pharmacist that coverage would continue only after each of them had spent $3,600 on drugs. The Starks are in their 70s and retired.

"We started wondering what in the hell was going on," said the Starks' daughter, Cheri Brudevold, who cares for her parents. Initially, she suspected it to be a scam. But it was not.

The Starks had actually tumbled into a complicated technical gap called the "doughnut hole" — a gap specifically designed as part of the Part D program that compels Medicare patients to pay the whole amount of their drug costs for a period after they reach a certain spending threshold. More than 3 million Americans will be affected by this gap in 2006. The average senior’s drug purchase this year will reach the threshold next month. When this happens, many ignorant seniors will find it as troublesome as it was unexpected.

"I've never known insurance that has this hole in the middle," said Liz Mercer, a Part D expert with the Statewide Health Insurance Benefits Advisors (SHIBA) program at the state Insurance Commissioner's Office. "It doesn't feel logical at all."

To provide affordable coverage for seniors with average drug expenses and to provide catastrophic coverage for people with huge drug bills were the 2 chief aims of the Congress that created Part D.

Medicare pays for two-thirds of the first $2,250 in purchases under the standard Part D plan. After $5,100, it pays 95% of the drugs’ cost. But in between lies the --doughnut hole — $2,850 wide!! The seniors must pay that from th
'"/>




Page: 1 2 3 4

Related medicine news :

1. Abstain from sex- the latest mantra of American teens
2. Clintons new problem - Is the outgoing American president suffering from skin cancer?
3. FDA attacks American Red Cross for blood violations
4. Poll Finds Many Americans Misinformed About Cancer
5. Poll Finds Many Americans Misinformed About Cancer
6. Hypertension Drug of Choice for African Americans
7. American scientists alter gene makeup of babies
8. 38 million Americans including 14 million children left to combat hunger
9. Americans Consume Far Too Much Salt and Sodium
10. Americans Growing Out Of Shape
11. Rise in Stress among Americans
Post Your Comments:
(Date:7/25/2008)... - 180-Days of Marketing Exclusivity Begin...l/ -- Watson,Pharmaceuticals, Inc. (NYSE: WPI ), ...ced today that its subsidiary has commenced commer...psules USP product in the 40mg,strength from its D...on,with the launch, Watson has 180 days of marketi...
(Date:7/25/2008)...AUMBURG, Ill., July 25 /PRNewswire/ -- Sagent Phar...maceutical company, today announced that it,has la...antiarrhythmic,indicated for the treatment and pro...llation and hemodynamically unstable ventricular,t...ular heart beat.,Sagent,s amiodarone HCl injection...
(Date:7/25/2008)...LSBAD, Calif., July 25 /PRNewswire/ -- AutoGenomic...ration statement on Form S-1 with the,Securities a...itial public,offering of shares of its common stoc...red, all of which are expected to be offered by,Au...ring, have not yet been,determined., J.P. Morgan ...
(Date:7/25/2008)... New program delivers immediate ... [24-hour telephone access to language interprete...ing multilingual solutions. , ... LLE® http://www.lle-inc.com/index.html [(L...ovider of interpretation, translation, and languag...
Breaking Medicine News(10 mins):Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3
...nmentally friendly, if new figures released by the...ything to go by. The growth in emissions from va...ed the reduction in carbon dioxide emissions due t...ore efficient cars, the report said. The total CO...
...g fast in Massachusetts, resulting in calls mosqui... reservations . EEE is a potentially deadly encep...es are reluctant to go in for wholesale because of...lists. Nine regional control projects in the stat...
...ards the development of a technique that could be ...ariant CJD . The technique, which has so far been...and accelerating the replication of prions - abnor...ain tissue and are thought to cause the disease. &...
Hormone Replacement Therapy Liberation at a Cost
Other Medicine News:Health News:Eastern Equine Encephalitis Spreading Its Tentacles in Massachusetts 2Health News:Eastern Equine Encephalitis Spreading Its Tentacles in Massachusetts 3Health News:Significant Advances in VCJD Prion Detection 2Health News:Hormone Replacement Therapy Liberation at a Cost 2Health News:Hormone Replacement Therapy Liberation at a Cost 3
(Date:7/24/2008)...re/ -- Headlines claiming "soy,products lower sper...ale,preliminary study that Dr. Jorge Chavarro, pu...recollected intake of soyfoods and not on,specific...ded by many,issues, thus I feel the results should...r. Tammy Hedlund, a researcher in prostate cancer,...
(Date:7/24/2008)... -- MacroChem Corporation (OTC,Bulletin Board: MAC...rial,involving 37 patients who completed a 48-week...y study of EcoNail, a topical antifungal,lacquer f...he composite,primary efficacy endpoint of the tria... (negative fungal culture and negative KOH) and cl...
(Date:7/23/2008)...y print edition of Clinical C... /- A Roche Diagnostics-sponsored,pil...pe natriuretic peptide,(NT-proBNP) confirms the po... in predicting the risk of cardiovascular adverse ...dal anti-inflammatory drugs of,the COX inhibitor c...
(Date:7/23/2008)...arma Inc., a company developing,breakthrough molec...graphy,(PET) market, announced positive Phase I re...cer for myocardial perfusion imaging. BFPET is,Flu...ete Phase I clinical,development., BFPET is a PET...in the,heart (myocardial perfusion). Myocardial pe...
Breaking Medicine Technology:Soyfoods Do Not Impact Sperm Count 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Rheumatoid Arthritis Treatment Guidelines Updated 22828 1Rheumatoid Arthritis Treatment Guidelines Updated 22828 2Rheumatoid Arthritis Treatment Guidelines Updated 22828 3First Nursing Facility Installation of Masimo Patient SafetyNet 28TM 29 Goes Live With Remarkable Results 22825 1First Nursing Facility Installation of Masimo Patient SafetyNet 28TM 29 Goes Live With Remarkable Results 22825 2First Nursing Facility Installation of Masimo Patient SafetyNet 28TM 29 Goes Live With Remarkable Results 22825 3First Nursing Facility Installation of Masimo Patient SafetyNet 28TM 29 Goes Live With Remarkable Results 22825 4First Nursing Facility Installation of Masimo Patient SafetyNet 28TM 29 Goes Live With Remarkable Results 22825 5American Airlines Miles for the Cure Campaign Raises More Than 24600 000 for Susan G Komen for the Cure 28R 29 22822 1American Airlines Miles for the Cure Campaign Raises More Than 24600 000 for Susan G Komen for the Cure 28R 29 22822 2American Airlines Miles for the Cure Campaign Raises More Than 24600 000 for Susan G Komen for the Cure 28R 29 22822 3First CyberKnife System to be Installed in Canada 22819 1First CyberKnife System to be Installed in Canada 22819 2First CyberKnife System to be Installed in Canada 22819 3First CyberKnife System to be Installed in Canada 22819 4
...ort Rationale for Targeting Pro-Inflammatory,Prote...e-FirstCall/ --,MedImmune, Inc. today announced th...ing a role for high mobility group box,protein-1 (...ology,of systemic autoimmune diseases such as syst...toid arthritis. Data to be,published in the May 20...
...pril 19, 2007 /PRNewswire-FirstCall/ --,VioQuest P...aceutical company focused on acquiring, developing...nounced data from its,preclinical studies of VQD- ...treatment of solid and hematologic tumors.,Pre-cli...2007,Annual Meeting of the American Association fo...
Other Medicine Technology:MedImmune Publishes New Data in Nature Immunology Demonstrating The,Role HMGB1 May Play in Systemic Autoimmune Diseases 2MedImmune Publishes New Data in Nature Immunology Demonstrating The,Role HMGB1 May Play in Systemic Autoimmune Diseases 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 2VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 4VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 5
Stat Fax 2600 is fully automatic microplate washer.
The Microtech Microplate Washer (220 V) is a flexible and ultra compact microplate washer. The system offers a wide choice of washing functions and sequences designed to handle most any microplate ap
PW 41 is a powerful, compact and programmable 2 x 8-channel microplate washers/aspirators, with built-in vacuum and dispensing pumps. Dispense and aspirate head heights ,are user-adjustable, with v
LHW is a solid made, manual plate washer for low throughput use. Separate valves for dispense and aspirate function ensure proper washing results. LHW8 comes complete with a stand and all necessary t
Medicine Products: